Barquet N, Domingo P, Caylà J A, González J, Rodrigo C, Fernández-Viladrich P, Moraga-Llop F A, Marco F, Vázquez J, Sáez-Nieto J A, Casal J, Canela J, Foz M
CAP Gràcia, Institut Català de la Salut, Barcelona, Spain.
JAMA. 1997 Aug 13;278(6):491-6. doi: 10.1001/jama.278.6.491.
Meningococcal disease is associated with significant morbidity and mortality. Development of a prognostic model based on clinical findings may be useful for identification and management of patients with meningococcal infection.
To construct and validate a bedside model and scoring system for prognosis in meningococcal disease.
Prospective, population-based study.
Twenty-four hospitals in the metropolitan area of Barcelona, Spain.
A total of 907 patients with microbiologically proven meningococcal disease. Patients diagnosed with meningococcal disease from 1987 through 1990 were used to develop the prognostic model, and those diagnosed in 1991 and 1992 were used to validate it.
Clinical independent prognostic factors for mortality in meningococcal disease. The association between outcome and independent prognostic factors was determined by logistic regression analysis. A scoring system was constructed and tested using receiver operating characteristic curves.
Among 624 patients in the derivation set, 287 (46%) were male, the mean age was 12.4 years, and 34 patients (5.4%) died. Among 283 patients in the validation set, 124 (43.8%) were male, the mean age was 12.7 years, and 17 patients (6.0%) died. In multivariate analysis, independent predictors of death were hemorrhagic diathesis (odds ratio [OR], 101; 95% confidence interval [CI], 30-333), focal neurologic signs (OR, 25; 95% CI, 7-83), and age 60 years or older (OR, 10; 95% CI, 3-34), whereas receipt of adequate antibiotic therapy prior to admission was associated with reduced likelihood of death (OR, 0.09; 95% CI, 0.02-0.4). Hemorrhagic diathesis was scored with 2 points, presence of focal neurologic signs with 1 point, age of 60 years or older with 1 point, and preadmission antibiotic therapy was scored as -1. The clinical scores of -1, 0, 1, 2, and 3 or more points were associated with a probability of death of 0%, 2.3%, 27.3%, 73.3%, and 100%, respectively.
Hemorrhagic diathesis, focal neurologic signs, and age of 60 years or older were independent predictors of death in meningococcal disease, whereas receipt of adequate antibiotic therapy was associated with a more favorable prognosis. The scoring system presented is simple, is based on findings readily available at the bedside, and may be useful to help guide aggressive therapy.
脑膜炎球菌病与显著的发病率和死亡率相关。基于临床发现开发一种预后模型可能有助于识别和管理脑膜炎球菌感染患者。
构建并验证一种用于脑膜炎球菌病预后的床边模型和评分系统。
前瞻性、基于人群的研究。
西班牙巴塞罗那大都市区的24家医院。
总共907例经微生物学证实的脑膜炎球菌病患者。1987年至1990年诊断为脑膜炎球菌病的患者用于开发预后模型,1991年和1992年诊断的患者用于验证该模型。
脑膜炎球菌病死亡的临床独立预后因素。通过逻辑回归分析确定结局与独立预后因素之间的关联。构建一个评分系统并使用受试者工作特征曲线进行测试。
在推导集中的624例患者中,287例(46%)为男性,平均年龄为12.4岁,34例(5.4%)死亡。在验证集中的283例患者中,124例(43.8%)为男性,平均年龄为12.7岁,17例(6.0%)死亡。在多变量分析中,死亡的独立预测因素为出血素质(比值比[OR],101;95%置信区间[CI],30 - 333)、局灶性神经体征(OR,25;95%CI,7 - 83)和60岁及以上年龄(OR,10;95%CI,3 - 34),而入院前接受充分的抗生素治疗与死亡可能性降低相关(OR,0.09;95%CI,0.02 - 0.4)。出血素质评分为2分,存在局灶性神经体征评分为1分,60岁及以上年龄评分为1分,入院前抗生素治疗评分为 -1分。临床评分为 -1分、0分(此处原文有误,根据逻辑应为0分)、1分、2分和3分及以上分别与死亡概率0%、2.3%、27.3%、73.3%和100%相关。
出血素质、局灶性神经体征和60岁及以上年龄是脑膜炎球菌病死亡的独立预测因素,而接受充分的抗生素治疗与更有利的预后相关。所呈现的评分系统简单,基于床边易于获得的发现,可能有助于指导积极治疗。